We report a novel germline ERCC2 mutation and a somatic BRCA2 mutation in a patient with AdCC, enriching the mutational landscape of AdCC and offering insights into precision therapy. The gene discussed is BRCA2; the disease is adrenocortical carcinoma, hereditary.